摘要
目的 :介绍韩国药物经济学评价应用于医保报销决策的经验,从而为我国开展类似探索提供借鉴。方法:文献综述。结果:韩国是亚洲第一个将规范的药物经济学证据应用于医保报销决策的国家,也是目前亚洲唯一一个强制执行药物经济学评价的国家。韩国医保报销政策改革对于缓解医疗费用过快上涨发挥了重要作用。结论:药物经济学评价应用于医保报销决策是合理配置稀缺医疗卫生资源的重要手段,韩国在这方面进行了积极的探索,但研究和实践都有待进一步深入,总结其经验和问题对我国今后开展类似工作有重要借鉴意义。
Objective：To introduce South Korea’s experience of applying pharmacoeconomic evaluation（PE） in reimbursement decision-making and to provide references for our country when carrying out similar explorations. Methods：Literature review. Results：In Asia,South Korea is the first country applying pharmacoeconomic evaluation in reimbursement decision-making and the only country that enforces pharmacoeconomic evaluation. Korea’s medical reimbursement policy reform has played an important role in alleviating the pressure of rapidly increasing medical costs. Conclusion：Pharmacoeconomic evaluation is an important tool of rational allocation of scarce health resources. South Korea has made an active exploration in this regard. However,studies and practices remain to be further deepend. Summarizing its experiences and problems can bring important references to China in the similar exploration of applying pharmacoeconomic evaluation in reimbursement decision-making.
出处
《中国卫生资源》
2014年第4期270-273,290,共5页
Chinese Health Resources
基金
美国中华医学基金会(CMB)基金资助项目(11-067)
关键词
药物经济学评价
医疗保险
报销决策
韩国
pharmacoeconomic evaluation
health insurance
reimbursement decision-making
South Korea
